Phase 2b Study to Evaluate the Efficacy and Safety of ISB 830 in Adults With Moderate to Severe Atopic Dermatitis
Conditions
- Moderate to Severe Atopic Dermatitis
Interventions
- DRUG: ISB 830 - Part 1 Group 1
- DRUG: ISB 830 - Part 1 Group 2
- DRUG: ISB 830 - Part 1 Group 3
- DRUG: Placebo - Part 1 Group 4
- DRUG: ISB 830 - Part 2 Group 5
- DRUG: Placebo - Part 2 Group 6
Sponsor
Ichnos Sciences SA
Collaborators